| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 03/03/1993 | EP0528926A1 Soluble peptide analogues containing binding sites |
| 03/03/1993 | EP0528835A1 Cyclic peptides and their use |
| 03/03/1993 | EP0364442B1 Therapeutical compositions against psoriasis |
| 03/03/1993 | CN1069522A Intercellular adhesion molecule-3 and its binding ligands |
| 03/02/1993 | US5191084 Phenyl pyrazolidinones as bronchodilators and anti-inflammatory agents |
| 03/02/1993 | US5191067 For treatment of fibroblast growth factor mediated pathophysiological conditions |
| 03/02/1993 | US5190937 Lactam derivatives |
| 03/02/1993 | US5190936 Process for improving the therapeutic efficacy of fat-soluble corticosteroids and composition for carrying out this process |
| 03/02/1993 | US5190935 Vitamin d analogues |
| 03/02/1993 | CA1314048C Quinolinylmethoxyphenylsulfonyl-carboxamides as anti-inflammatory/antiallergic agents |
| 03/02/1993 | CA1314044C Imidazopyridine derivatives |
| 03/02/1993 | CA1314012C Process for the preparation of 2-arylpropionic acids |
| 03/01/1993 | CA2076929A1 Substituted mandelic acid derivatives, processes for their preparation and their use in medicaments |
| 02/24/1993 | EP0528633A1 Pyrimidinyl acetamides as elastase inhibitors |
| 02/24/1993 | EP0528495A1 Azacyclic compounds, processes for their preparation and pharmaceutical compositions containing them |
| 02/24/1993 | EP0528468A1 Use of triclosan for the manufacture of a medicament for inhibiting cyclooxygenase |
| 02/24/1993 | EP0528337A1 New thiazolylbenzofuran derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same |
| 02/24/1993 | EP0528312A2 Cyclic peptides and use thereof |
| 02/24/1993 | EP0528172A1 (2-Alkyl-3-pyridyl)methylpiperazine derivatives as PAF antagonists |
| 02/24/1993 | EP0528135A1 Uses of 9,12,15-octadecatrien-6-ynoic acid |
| 02/24/1993 | EP0527764A1 Phosphonopeptides with collagenase inhibiting activity |
| 02/24/1993 | CA2076553A1 1,7-fused 2-(piperazinoalkyl) indole derivatives, processes and intermediates for their preparation, and pharmaceutical compositions containing them |
| 02/23/1993 | US5189178 Preventing protein destruction |
| 02/23/1993 | US5188841 Sustained release pharmaceutical formulations |
| 02/23/1993 | CA2076558A1 Pharmaceutical compositions containing bradykinin antagonists for local use on the nose and eyes |
| 02/21/1993 | CA2073138A1 Use of 9,12,15-octadecatriene-6-ynoic acid |
| 02/18/1993 | WO1993003059A1 Cyclic hexapeptides as tachyquinin antagonists, their preparation and pharmaceutical compositions thereof |
| 02/18/1993 | WO1993002699A1 Use of collagen for the treatment of degenerative joint ailments |
| 02/18/1993 | WO1993002693A2 Use of interleukin-10 analogs or antagonists to treat endotoxin- or superantigen induced toxicity |
| 02/18/1993 | WO1992019613A3 1,2-dithiole-3-thione derivative-based therapeutical compositions |
| 02/18/1993 | DE4226866A1 Pflanzliche zusammensetzung mit niedrigem molekulargewicht Herbal composition of low molecular weight |
| 02/17/1993 | CA2076192A1 Thiazolylbenzofuran derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same |
| 02/17/1993 | CA2075662A1 Chromophore containing compounds and their use in determining interleukin-1b convertase activity |
| 02/16/1993 | US5187286 Antiinflammatory agents, antiallergens |
| 02/16/1993 | US5187173 2-saccharinylmethyl and 4,5,6,7-tetrahydro-2-saccharinylmethyl phosphates, phosphonates and phosphinates useful as proteolytic enzyme inhibitors and compositions and method of use thereof |
| 02/16/1993 | US5187157 Peptide boronic acid inhibitors of trypsin-like proteases |
| 02/16/1993 | US5187153 Methods of treatment using Alzheimer's amyloid polypeptide derivatives |
| 02/16/1993 | US5187089 Variants wherein there are nonpolar amino acid substitutions at the substrate binding site |
| 02/15/1993 | CA2075464A1 Low molecular weight vegetable composition |
| 02/10/1993 | EP0527117A1 Substituted cyclopropylamino-1,3,5-triazines |
| 02/10/1993 | EP0527101A1 New pharmaceutical compositions derived from acid fraction of the lipid extracts of sabal serrulata, with antagonistic adrenergic effect and method to obtain these compositions |
| 02/10/1993 | EP0527069A1 Derivatives of pyrrolidine and thiazolidine, their preparation, and pharmaceutical compositions containing them |
| 02/10/1993 | EP0527042A2 3-deoxy-mannosamine derivatives and process for their preparation |
| 02/10/1993 | EP0526905A2 Multimers of the soluble forms of TNF receptors, their preparation and pharmaceutical compositions containing them |
| 02/10/1993 | EP0526840A1 Condensed naphthyridine derivatives |
| 02/10/1993 | EP0445156B1 Agents for treating chronic inflammatory diseases of the intestines |
| 02/10/1993 | CN1068734A Therapeutic agent |
| 02/09/1993 | US5185442 New diazepines substituted in the 6-position, processes for their preparation and their use as pharmaceutical compositions |
| 02/09/1993 | US5185377 Applying locally or by inhalation as antiinflammatory agent, antiallergen, bronchodilator, antiasthmatic, antipsoriatic |
| 02/09/1993 | US5185350 For Alzheimer*s, memory dysfunctions, antidepressants, antiinflammatory agents |
| 02/09/1993 | US5185326 Antiischemic agents |
| 02/09/1993 | CA2075673A1 (2-alkyl-3-pyridyl)methylpiperazine derivatives |
| 02/07/1993 | CA2075336A1 3-deoxy-mannosamine derivatives and process for their preparation |
| 02/04/1993 | WO1993002203A1 Fr901451 substance, process for preparation thereof and use thereof |
| 02/04/1993 | WO1993002191A1 Humanized antibody against cd18 |
| 02/04/1993 | WO1993002090A1 Manganese complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide |
| 02/04/1993 | WO1993002081A1 Novel benzopyrido piperylidene compounds, compositions, methods of manufacture and methods of use |
| 02/04/1993 | WO1993002043A1 Dimethylacetoacetamides, methods of preparing them, and drugs containing them |
| 02/04/1993 | WO1993001816A1 Method and composition for treatment of gastric and duodenal disorders and new pge2-derivatives |
| 02/04/1993 | WO1993001813A1 Platelet activating factor antagonists |
| 02/04/1993 | DE4125400A1 Verwendung von kollagen zur behandlung von degenerativen gelenkprozessen Use of collagen for the treatment of degenerative joint processes |
| 02/04/1993 | CA2114023A1 Method and composition for treatment of gastric and duodenal disorders and new pge2-derivatives |
| 02/04/1993 | CA2114009A1 Novel benzopyrido piperidylidene compounds, compositions, methods of manufacture and methods of use |
| 02/04/1993 | CA2112562A1 Platelet activating factor antagonists |
| 02/03/1993 | EP0526402A1 Heteroaryl substituted hydroxylamine derivatives as lipoxygenase inhibitors |
| 02/03/1993 | EP0526395A1 Arylalkylamine derivatives, process for their preparation and pharmaceutical compositions containing them |
| 02/03/1993 | EP0526192A2 Hexapeptide |
| 02/03/1993 | EP0525973A2 Substituted azetidinones as anti-inflammatory and antidegenerative agents |
| 02/03/1993 | EP0525686A1 Dimethylacetylacetic acid amides, process for their preparation and pharmaceutical compositions |
| 02/03/1993 | EP0525571A1 Quinolin-2-yl-methoxybenzylhydroxyureas as lipoxygenase inhibitors |
| 02/03/1993 | EP0525420A1 Pseudopeptides and dipeptides characterised by a substituted methyl ketone moiety at the C-terminus as thiol protease inhibitors |
| 02/03/1993 | EP0525054A1 Modified heparin binding growth factors |
| 02/03/1993 | EP0525033A1 4-(oxygen, sulfur or nitrogen substituted)-methyl 5-hydroxy-2(5h)-furanones as anti-inflammatory agents |
| 02/03/1993 | EP0525002A1 2[5H]-FURANONES SUBSTITUTED IN THE 3 POSITION, AS Ca 2+ CHANNEL ANTAGONISTS AND ANTI-INFLAMMATORY AGENTS |
| 02/03/1993 | EP0524979A1 2(5h)-furanones substituted in the 5 and or in the 4 position, as anti-inflammatory agents |
| 02/02/1993 | US5183906 2- and 5-alkyl and phenyl substituted 4-(1-hydroxy, 1-acyloxy or 1-carbamoyloxy)-5-hydroxy-2 (5h)-furanones as anti-inflammatory agents |
| 02/02/1993 | CA1313372C Polycyclic heterocyclic derivatives, a process for their preparation and their application to veterinary and human medicine |
| 02/01/1993 | CA2074788A1 Qinolin-2-yl-methoxybenzylhydroxyureas |
| 01/31/1993 | CA2074967A1 Hexapeptide |
| 01/31/1993 | CA2074797A1 Certain heteroaryl substituted hydroxylamine derivatives |
| 01/27/1993 | EP0524899A1 Recombinant DNA molecules coding for the VB2 T cell receptor, method of preparation, antibodies and medicaments containing them |
| 01/27/1993 | EP0524784A1 Benzopyrido piperidylidene compounds as PAF antagonists |
| 01/27/1993 | EP0524633A2 Pharmaceutical composition suitable for influencing the reticuloendothelial system |
| 01/27/1993 | EP0524602A2 Compositions for the treatment of inflammations of the skin |
| 01/27/1993 | EP0524587A1 Therapeutic compositions for intranasal administration which include ketorolac TM |
| 01/27/1993 | EP0524582A1 Diclofenac sodium plaster |
| 01/27/1993 | EP0524180A1 Taste masking of ibuprofen by fluid bed coating. |
| 01/27/1993 | CN1068332A Pyrazolopyrimidine and pyrimidinyl bisphosphonic esters as anti-inflammatories |
| 01/27/1993 | CN1068327A Process for preparing 14-0-acylate of aconite alkaloid type compounds |
| 01/26/1993 | CA2072680A1 Substituted cyclopropylamino-1,3,5-triazines |
| 01/26/1993 | CA1313189C Immunomodulatory azaspiranes |
| 01/26/1993 | CA1313137C Method of inhibiting interleukin-1 activity |
| 01/25/1993 | CA2074568A1 Dimethyl acetoacetamides, process for their preparation and pharmaceuticals |
| 01/24/1993 | CA2074216A1 Topical anti-fungal agents having anti-inflammatory activity |
| 01/23/1993 | CA2074211A1 Arylalkylamine derivatives |
| 01/21/1993 | WO1993001215A1 Pla2 inhibitory compounds |
| 01/21/1993 | WO1993001211A1 Peptide which abrogates tnf and/or lps toxicity |
| 01/21/1993 | WO1993001198A1 Pyrazolopyrimidine and pyrimidinyl bisphosphonic esters as anti-inflammatories |
| 01/21/1993 | WO1993001175A1 14-O-p-CHLOROBENZOYLACONINE AND ANALGESIC/ANTIINFLAMMATORY AGENT |
| 01/21/1993 | WO1993001167A1 Pyrrolidine and thiazolidine derivatives, preparation thereof and drugs containing same |